Search results for "Randomized Controlled Trials as Topic"

showing 10 items of 435 documents

Exercise for depression in older adults: a meta-analysis of randomized controlled trials adjusting for publication bias

2016

OBJECTIVE: To evaluate the antidepressant effects of exercise in older adults, using randomized controlled trial (RCT) data. METHODS: We conducted a meta-analysis of exercise in older adults, addressing limitations of previous works. RCTs of exercise interventions in older people with depression (≥ 60 years) comparing exercise vs. control were eligible. A random-effects meta-analysis calculating the standardized mean difference (SMD) (95% confidence interval [95%CI]), meta-regressions, and trim, fill, and fail-safe number analyses were conducted. RESULTS: Eight RCTs were included, representing 138 participants in exercise arms and 129 controls. Exercise had a large and significant effect on…

Malemedicine.medical_specialtylcsh:RC435-571Subgroup analysisReview Articlenot knownlaw.invention03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationRandomized controlled triallawRisk Factorslcsh:PsychiatryMedicineHumans030212 general & internal medicineExerciseolder adultsAgedRandomized Controlled Trials as Topicpublication biasAged 80 and overDepressive Disorder Majorbusiness.industryAge FactorsPublication biasMiddle AgedConfidence intervalExercise Therapymeta-analysisPsychiatry and Mental healthTreatment OutcomeStrictly standardized mean differenceMeta-analysisdepressionPhysical therapyFemalebusinessAnaerobic exercise030217 neurology & neurosurgeryManagement of depressionBrazilian Journal of Psychiatry
researchProduct

Clinical trials with a new atypical antipsychotic (Aripiprazole): gender specific information analysis.

2008

In 1993, the Food and Drug Administration (FDA) published a guideline for the study and evaluation of gender-related differences in clinical trials. However, the extent of the implementation of these recommendations has not been systematically reviewed.To determine the proportion of women in clinical trials of Aripiprazole, a new atypical antipsychotic, and to analyze the resulting information on a gender-specific basis.A systematic review was conducted in Medline to identify randomized trials that compared this new antipsychotic drug with placebo or with typical or atypical antipsychotics in patients diagnosed with schizophrenia. The FDA Guideline was followed for the study and evaluation …

Malemedicine.medical_specialtymedicine.drug_classMEDLINEAripiprazoleAtypical antipsychoticQuinolonesPlaceboPiperazineslaw.inventionRandomized controlled triallawInternal medicinemedicineHumansSex DistributionPsychiatryRandomized Controlled Trials as Topicbusiness.industryUnited States Food and Drug AdministrationGeneral MedicineGuidelinemedicine.diseaseUnited StatesClinical trialTreatment OutcomeSchizophreniaSchizophreniaAripiprazoleFemaleSchizophrenic Psychologybusinessmedicine.drugAntipsychotic AgentsWomenhealth
researchProduct

Effectiveness of Exergame Intervention on Walking in Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

2020

Abstract Objective The objective of this review was to systematically evaluate the effectiveness of exergaming on walking in older adults. In addition, the aim was to investigate the relationship between the exergaming effect and age, baseline walking performance, exercise traits, technology used, and the risk of bias. Methods A literature search was carried out in the databases MEDLINE, CINAHL, CENTRAL, EMBASE, WoS, PsycInfo, and PEDro up to January 10, 2020. Studies with a randomized controlled trial design, people ≥60 years of age without neurological disorders, comparison group with other exercise or no exercise, and walking-related outcomes were included. Cochrane RoB2, meta-analysis, …

Malemedicine.medical_specialtymedicine.medical_treatmentMEDLINEPsychological interventionPhysical Therapy Sports Therapy and RehabilitationHealth PromotionWalkingPsycINFOCINAHLlaw.inventionRandomized controlled triallawHumansMedicineMuscle StrengthExerciseAgedRandomized Controlled Trials as TopicRehabilitationbusiness.industryAge FactorsExercise TherapyVideo GamesStrictly standardized mean differenceMeta-analysisPhysical therapyFemalebusinessAttitude to HealthPhysical Therapy
researchProduct

Recovery of Lower Extremity Performance After Hip Fracture Depends on Prefracture and Postdischarge Mobility : A Subgroup Analysis of a Randomized Re…

2016

Malemedicine.medical_specialtymedicine.medical_treatmentSubgroup analysisrehabilitation03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationActivities of Daily LivingmedicineHumans030212 general & internal medicineAgedRandomized Controlled Trials as TopicAged 80 and overHip fractureRehabilitationHip Fracturesbusiness.industryta3141Recovery of FunctionMiddle Agedmedicine.diseasemobilityhip fracturePhysical therapylower extremityFemaleGeriatrics and Gerontologybusiness030217 neurology & neurosurgeryperformanceJournal of the American Geriatrics Society
researchProduct

The effects of mothers’ musical background on sedentary behavior, physical activity, and exercise adherence in their 5-6-years-old children using mov…

2017

Objectives The purpose of this study was to examine whether mothers’ musical background has an effect on their own and their children’s sedentary behavior (SB) and physical activity (PA). The aim was also to assess children’s and their mothers’ exercise adherence when using movement-to-music video program. Design Sub-group analysis of an intervention group in a randomized controlled trial (ISRCTN33885819). Method Seventy-one mother-child-pairs were divided into two categories based on mothers’ musical background. Each pair performed 8 weeks exercise intervention using movement-to-music video program. SB and PA were assessed objectively by accelerometer, and exercise activity, fidelity, and …

Malemusic perceptionLiikuntatiede - Sport and fitness sciencesCultureChild BehaviorSocial Scienceslcsh:Medicinephysical activityMusicalIntervention groupLogistic regressionlaw.inventionFamilies0302 clinical medicineRandomized controlled triallawOdds RatioMedicine and Health SciencesPsychologyMedicinePublic and Occupational Health030212 general & internal medicineChildlcsh:Scienceta315Randomized Controlled Trials as TopicMultidisciplinaryexerciseparenting behaviormusikaalisuusExercise adherenceSedentary behavioräiditMother-Child RelationsSports SciencehumanitiesChild PreschoolEngineering and TechnologyFemaleSensory Perceptionfyysinen aktiivisuusResearch ArticleAdultmedicine.medical_specialtyDrug Research and DevelopmentaccelerometersmusiikkiPhysical activityResearch and Analysis Methods03 medical and health scienceschildrenHumansClinical TrialsSports and Exercise MedicinelapsetPharmacologyMusic CognitionExercise interventionbehaviorbusiness.industrylcsh:RCognitive PsychologyBiology and Life Sciences030229 sport sciencesRandomized Controlled TrialsLogistic ModelsAge GroupsPhysical FitnessPeople and PlacesPhysical therapyCognitive SciencePopulation Groupingslcsh:QSedentary BehaviorElectronicsClinical MedicinebusinessMusicNeuroscience
researchProduct

Eminence, or rather eloquence, or rather economy-based medicine?

2004

Marketing of Health Servicesbusiness.industryUrologyObstetrics and GynecologyHealth Care CostsUterine ProlapsePractice Guidelines as TopicQuality of LifeEconomic historyHumansMedicineFemalebusinessFecal IncontinenceSocieties MedicalRandomized Controlled Trials as TopicInternational Urogynecology Journal and Pelvic Floor Dysfunction
researchProduct

Chemotherapy for advanced gastric cancer

2017

Background Gastric cancer is the fifth most common cancer worldwide. In "Western" countries, most people are either diagnosed at an advanced stage, or develop a relapse after surgery with curative intent. In people with advanced disease, significant benefits from targeted therapies are currently limited to HER-2 positive disease treated with trastuzumab, in combination with chemotherapy, in first-line. In second-line, ramucirumab, alone or in combination with paclitaxel, demonstrated significant survival benefits. Thus, systemic chemotherapy remains the mainstay of treatment for advanced gastric cancer. Uncertainty remains regarding the choice of the regimen. Objectives To assess the effica…

Medicine General & Introductory Medical Sciences0301 basic medicineOncologymedicine.medical_specialtymedicine.medical_treatmentDocetaxelIrinotecanRamucirumab03 medical and health sciences0302 clinical medicineStomach NeoplasmsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsHumansMedicineAnthracyclinesPharmacology (medical)Randomized Controlled Trials as TopicChemotherapyPerformance statusbusiness.industryCombination chemotherapyOxaliplatinSurgeryRegimenAnthracyclines/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Camptothecin/administration & dosage; Camptothecin/analogs & derivatives; Cisplatin/administration & dosage; Fluorouracil/administration & dosage; Humans; Randomized Controlled Trials as Topic; Stomach Neoplasms/drug therapy; Stomach Neoplasms/mortality; Taxoids/administration & dosage030104 developmental biologyDocetaxel030220 oncology & carcinogenesisCamptothecinTaxoidsFluorouracilCisplatinbusinessEpirubicinmedicine.drugCochrane Database of Systematic Reviews
researchProduct

Urinary Tartaric Acid, a Biomarker of Wine Intake, Correlates with Lower Total and LDL Cholesterol.

2021

Postmenopausal women are at higher risk of developing cardiovascular diseases due to changes in lipid profile and body fat, among others. The aim of this study was to evaluate the association of urinary tartaric acid, a biomarker of wine consumption, with anthropometric (weight, waist circumference, body mass index (BMI), and waist-to-height ratio), blood pressure, and biochemical variables (blood glucose and lipid profile) that may be affected during the menopausal transition. This sub-study of the PREDIMED (Prevención con Dieta Mediterránea) trial included a sample of 230 women aged 60–80 years with high cardiovascular risk at baseline. Urine samples were diluted and filtered, and tartari…

Mediterranean dietmenopauseWineUrinechemistry.chemical_compoundTX341-641TartratesRandomized Controlled Trials as TopicAged 80 and overNutrition and Dieteticsmedicine.diagnostic_testAnthropometryMiddle Agedlipid profilebody fatCholesterolCardiovascular DiseasesFemaleMenopausaPREDIMEDcardiovascular riskmedicine.medical_specialtyWaistAlcohol DrinkingÀcid tàrtricArticleInternal medicineMediterranean dietmedicineHumanspolyphenolsAgedWinebusiness.industryCholesterolMalalties cardiovascularsNutrition. Foods and food supplybiomarkersmediterranean dietCholesterol LDLEndocrinologyCross-Sectional StudieschemistryHeart Disease Risk Factorstartaric acidLipid profilebusinessBody mass indexFood ScienceLipoproteinNutrients
researchProduct

Pegylated liposomal doxorubicin in the management of ovarian cancer

2014

Ovarian cancer is the leading cause of death among gynecological tumors. Carboplatin/paclitaxel represents the cornerstone of front-line treatment. Instead, there is no consensus for management of recurrent/progressive disease, in which pegylated liposomal doxorubicin (PLD) ± carboplatin is widely used. We performed a systematic review and metaanalysis to evaluate impact of PLD-based compared with no-PLD-based regimens in the ovarian cancer treatment. Data were extracted from randomized trials comparing PLD-based treatment to any other regimens in the January 2000-January 2013 time-frame. Study end-points were overall survival (OS), progression free survival (PFS), response rate (RR), CA125…

MetaanalysiOncologyCancer Researchmedicine.medical_specialtyendocrine system diseasesPharmacologyarian cancerDisease-Free SurvivalPolyethylene Glycolslaw.inventionchemistry.chemical_compoundRandomized controlled triallawOvPegylated liposomal doxorubicinInternal medicinemedicineHumansProgression-free survivalSystemic chemotherapyProportional Hazards ModelsRandomized Controlled Trials as TopicOvarian NeoplasmsPharmacologyAntibiotics Antineoplasticbusiness.industryProportional hazards modelHazard ratiomedicine.diseaseCarboplatinTreatment OutcomeOncologychemistryTolerabilityDoxorubicinClinical StudyMolecular MedicineFemaleRandomized clinical trialbusinessOvarian cancerProgressive diseaseCancer Biology & Therapy
researchProduct

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D…

2009

Background The choice of non-typeable Haemophilus influenzae Protein D as main carrier protein in the candidate 10-valent pneumococcal conjugate vaccine (PHiD-CV, GlaxoSmithKline Biologicals), was driven in part to avoid carrier-mediated suppression and possible bystander interference with coadministered vaccines. Immunogenicity data from 3 primary and 2 booster vaccination studies were assessed for possible impacts of PHiD-CV coadministration on immune responses to routinely administered childhood vaccines, in comparison to 7-valent pneumococcal conjugate vaccine (7vCRM) coadministration. Methods Randomized, controlled studies in which PHiD-CV or 7vCRM vaccines were coadministered with DTP…

Microbiology (medical)Heptavalent Pneumococcal Conjugate VaccineLipoproteinsImmunization SecondaryMeningococcal VaccinesBooster dosemedicine.disease_causeAntibodies Viralcomplex mixturesPneumococcal conjugate vaccineHaemophilus influenzaePneumococcal VaccinesBacterial ProteinsConjugate vaccineHeptavalent Pneumococcal Conjugate VaccineMedicineHumansHepatitis B VaccinesVaccines CombinedDiphtheria-Tetanus-Pertussis VaccineImmunization ScheduleHaemophilus VaccinesRandomized Controlled Trials as TopicVaccines Conjugatebusiness.industryImmunization ProgramsDiphtheriaImmunogenicityVaccinationInfantImmunoglobulin Dmedicine.diseaseVirologyAntibodies BacterialVaccinationPoliovirus VaccinesInfectious DiseasesTreatment OutcomePediatrics Perinatology and Child HealthImmunologybusinessCarrier Proteinsmedicine.drugThe Pediatric infectious disease journal
researchProduct